AXSOME THERAPEUTICS, INC. Finite-Lived Intangible Assets, Accumulated Amortization
AXSOME THERAPEUTICS, INC. (AXSM) had Finite-Lived Intangible Assets, Accumulated Amortization of $26.44 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2026-08-10
- 2026-06-30: Finite-Lived Intangible Assets, Accumulated Amortization $26.44M.
- 2026-03-31: Finite-Lived Intangible Assets, Accumulated Amortization $24.85M.
- 2025-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $23.28M.
- 2025-09-30: Finite-Lived Intangible Assets, Accumulated Amortization $21.67M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization | Finite-Lived Intangible Assets, Accumulated Amortization as first filed |
|---|---|---|
| 2026-06-30 | $26.44M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $24.85M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $23.28M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $21.67M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $20.07M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $18.48M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $16.91M 10-K · filed 2026-02-23 | -$16.91M 10-K · filed 2025-02-18 |
| 2024-09-30 | $15.30M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $13.69M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $12.10M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | -$10.51M 10-K · filed 2025-02-18 | |
| 2023-06-30 | $3.16M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $1.57M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | -$4.14M 10-K · filed 2024-02-23 | $4.14M 10-K · filed 2023-02-28 |
| 2022-09-30 | $2.53M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $925.65K 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |